"Provides patient support, education and research into a cure for Primary Immunodeficiency"

During the past decade, Canadian Immunodeficiency Research Collaborative conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Canadian Immunodeficiency Research Collaborative" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Canadian Immunodeficiency Research Collaborative" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "ViiV Healthcare" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Canadian Immunodeficiency Research Collaborative" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Canadian Immunodeficiency Research Collaborative" are "HIV Infections" (7 trials), "HIV" (3 trials), "HIV Infection" (1 trials) and "Maraviroc Concentrations in Semen" (1 trials). Many other conditions were trialed in "Canadian Immunodeficiency Research Collaborative" in a lesser frequency.

Most popular intervention types in "Canadian Immunodeficiency Research Collaborative" are "Drug" (8 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "ATV" (2 trials), "FTC/TDF" (2 trials), "ATV Placebo" (1 trials), "Background regimen" (1 trials) and "COBI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Canadian Immunodeficiency Research Collaborative" are 7 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Canadian Immunodeficiency Research Collaborative". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Canadian Immunodeficiency Research Collaborative, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Canadian Immunodeficiency Research Collaborative, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".